Nifty 50
- Tech Mahindra₹1,790140.00 (8.48%)
- InterGlobe Aviation₹4,686.90-91.40 (-1.91%)
- TCS₹2,465115.00 (4.89%)
- BSE₹3,363-65.00 (-1.90%)
- Infosys₹1,161.2051.20 (4.61%)
- Max Healthcare₹846-12.00 (-1.40%)
- Bharti Airtel₹1,90551.00 (2.75%)
- Tata Consumer ₹978.90-12.55 (-1.27%)
- Mahindra & Mahindra₹2,920.9059.20 (2.07%)
- Jio Financial ₹216.25-2.76 (-1.26%)
- Bajaj Finance₹98115.75 (1.63%)
- ONGC₹222-2.64 (-1.18%)
- Hindalco Industries₹90814.15 (1.58%)
- Bharat Electronics₹376.85-3.55 (-0.93%)
- HCL Technologies₹1,38020.00 (1.47%)
- Nestle₹1,265.50-10.30 (-0.81%)
- JSW Steel₹1,216.4016.00 (1.33%)
- Adani Enterprises₹2,680.90-19.10 (-0.71%)
- Grasim Industries₹2,92034.10 (1.18%)
- Bajaj Finserv₹1,720-12.00 (-0.69%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Sai Parenterals IPO Lists at ₹392 After 1.08x Subscription
Authored By HDFC SKY | Published at: Apr 2, 2026 01:02 PM IST
Sai Parenterals IPO lists at ₹392 on BSE, NSE after 1.08x subscription

Open Free Demat Account
Open Free Demat Account
Mumbai, April 2: Sai Parenterals Limited entered the secondary market on April 2, listing on both the BSE and NSE at ₹392 per share, exactly in line with the upper end of its issue price band.
The ₹408.79 crore IPO, open between March 24 and March 27, 2026, had already signalled a measured investor response during the bidding window.
Sai Parenterals IPO Subscription Status
The issue closed with an overall subscription of 1.08 times as of March 27, 2026.
Not weak, but not aggressive either. Participation remained selective.
Category-wise Sai Parenterals IPO Subscription Status
| Category | Subscription (times) |
| QIB | 1.34x |
| NII (HNI) | 2.46x |
| Retail | 0.12x |
| Total | 1.08x |
The demand pattern was uneven.
Non-institutional investors showed the strongest interest, while qualified institutional buyers offered moderate support. Retail participation, however, remained notably thin, leaving the segment significantly under-subscribed.
Sai Parenterals Day’s Wise Subscription Summary
| Day | Total Subscription |
| Day 1 | Tepid start |
| Day 2 | Gradual build-up |
| Day 3 | 1.08x |
Momentum built slowly. Most bids came in late.
Sai Parenterals IPO Timeline
| Event | Date |
| Issue Open Date | March 24, 2026 |
| Issue Close Date | March 27, 2026 |
| Basis of Allotment | March 30, 2026 |
| Initiation of Refunds | April 1, 2026 |
| Credit of Shares | April 1, 2026 |
| Listing Date | April 2, 2026 |
Brief Overview Of The IPO
The Sai Parenterals IPO comprised a fresh issue of ₹285 crore alongside an offer for sale of ₹123.79 crore, aggregating to ₹408.79 crore.
Shares were priced between ₹372 and ₹392, with the final issue price fixed at ₹392 per share. The lot size was set at 38 shares.
Sai Parenterals operates in the pharmaceutical manufacturing space, with a focus on injectable formulations and associated healthcare products.
With its shares now listed at the issue price, the company begins its journey in the public markets without any immediate re-rating on debut.
Source:
- https://www.nseindia.com/get-quote/equity/SAIPARENT/Sai-Parenterals-Limited
- https://www.nseindia.com/market-data/all-upcoming-issues-ipo
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
Disclaimer
At HDFC SKY*, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations.
HDFC SKY from HDFC Securities, one of most trusted trading platforms in India, has been recognized with the *Next-Gen Digi Content Awards 2025-26.
More IPO News
Open Free Demat Account
Open Free Demat Account





By signing up I certify terms, conditions & privacy policy

Join Us
Add as preferred source on Google













